The Economic Times
English EditionEnglish Editionहिन्दी
| E-Paper
Search
+

    Panacea Biotec appoints Susheel Umesh as Chief Executive of domestic formulations

    Synopsis

    Susheel Umesh brings in 27 years of experience, deep understanding of pharmaceutical industry, the company said. Panacea Biotec is a leading pharmaceutical and biotechnology company with established research, manufacturing and marketing capabilities.

    Panacea Biotec on Tuesday said it has appointed Susheel Umesh as the Chief Executive of domestic formulations.
    NEW DELHI: As part of its organisational restructuring programme, drug firm on Tuesday said it has appointed Susheel Umesh as the Chief Executive of domestic formulations.

    The company also announced the elevation of Rajeeva Kumar Mangalum as Chief Operating Officer for the pharmaceutical operations and Dinesh Singla as senior vice president- pharma research and pharma regulatory affairs, according to a regulatory filing.

    Umesh brings in 27 years of experience, deep understanding of pharmaceutical industry, the company said.

    Mangalum has 35 years of pharmaceutical manufacturing experience; out of which, he spent 25 years in Panacea Biotec.

    Singla comes with 24 years of pharmaceutical research experience out of which he has spent 12 years in Panacea Biotec.

    Panacea Biotec is a leading pharmaceutical and biotechnology company with established research, manufacturing and marketing capabilities.

    Shares of the company were trading 0.83 per cent higher at Rs 127 apiece on BSE.
    (Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Read before you invest. Insights on Panacea Biotec Ltd.. Explore Now
    The Economic Times